J9310 — Injection, rituximab, 100 mg
J9310 is a HCPCS Level II code for injection, rituximab, 100 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2018 and is not valid on new claims.
This code has been terminated
CMS terminated J9310 on December 31, 2018. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J9310
- Long descriptor
- Injection, rituximab, 100 mg
- Short descriptor
- Rituximab injection
- Added
- January 1, 1999
- Terminated
- December 31, 2018
- BETOS
- O1D
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J9310
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J9310 is not quite right, the correct code is very often within a few positions of it.
- J9302Injection, ofatumumab, 10 mg
- J9303Injection, panitumumab, 10 mg
- J9304Injection, pemetrexed (pemfexy), 10 mg
- J9305Injection, pemetrexed, not otherwise specified, 10 mg
- J9306Injection, pertuzumab, 1 mg
- J9307Injection, pralatrexate, 1 mg
- J9308Injection, ramucirumab, 5 mg
- J9309Injection, polatuzumab vedotin-piiq, 1 mg
- J9311Injection, rituximab 10 mg and hyaluronidase
- J9312Injection, rituximab, 10 mg
- J9313Injection, moxetumomab pasudotox-tdfk, 0.01 mg
- J9314Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg
- J9315Injection, romidepsin, 1 mgterminated
- J9316Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg
- J9317Injection, sacituzumab govitecan-hziy, 2.5 mg
- J9318Injection, romidepsin, non-lyophilized, 0.1 mg
Questions about J9310
What is HCPCS code J9310?
J9310 is a HCPCS Level II code for injection, rituximab, 100 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J9310?
The CMS HCPCS file marks J9310 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J9310 still valid?
No. J9310 was terminated on December 31, 2018 and should not be used on new claims.